Source:http://linkedlifedata.com/resource/pubmed/id/16542695
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0021761,
umls-concept:C0039194,
umls-concept:C0205225,
umls-concept:C0205263,
umls-concept:C0521447,
umls-concept:C0598312,
umls-concept:C0851827,
umls-concept:C1521761,
umls-concept:C1701901,
umls-concept:C1704259,
umls-concept:C1705987,
umls-concept:C1879547
|
pubmed:issue |
2
|
pubmed:dateCreated |
2006-7-3
|
pubmed:abstractText |
Interleukin (IL)-7 plays several roles critical to T cell maturation, survival, and homeostasis. Because of these functions, IL-7 is under investigation as an immune-modulator for therapeutic use in lymphopenic clinical conditions, including HIV. We reported that naive T cells, typically not permissive to HIV, can be productively infected when pre-treated with IL-7. We evaluated the mechanism by which IL-7-mediates this effect. IL-7 potently up-regulated the transcriptional factor NFAT, but had no effect on NFkappaB. Blocking NFAT activity using a number of reagents, such as Cyclosporin A, FK-506, or the NFAT-specific inhibitor known as VIVIT peptide, all markedly reduced IL-7-mediated induction of HIV replication in naive T cells. Additional neutralization of cytokines present in IL-7-treated cultures and/or those that have NFAT-binding sequences within their promotors indicated that IL-10, IL-4, and most significantly IFNgamma, all contribute to IL-7-induction of HIV productive replication in naive T cells. These data clarify the mechanism by which IL-7 can overcome the block to HIV productive infection in naive T cells, despite their quiescent cell status. These findings are relevant to the treatment of HIV disease and understanding HIV pathogenesis in the naive CD4+ T cell compartment, especially in light of the vigorous pursuit of IL-7 as an in vivo immune modulator.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0042-6822
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
5
|
pubmed:volume |
350
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
443-52
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16542695-Antigens, CD,
pubmed-meshheading:16542695-CD4-Positive T-Lymphocytes,
pubmed-meshheading:16542695-HIV,
pubmed-meshheading:16542695-Humans,
pubmed-meshheading:16542695-Interleukin-7,
pubmed-meshheading:16542695-Lymphocyte Activation,
pubmed-meshheading:16542695-NFATC Transcription Factors,
pubmed-meshheading:16542695-Reference Values,
pubmed-meshheading:16542695-T-Lymphocytes,
pubmed-meshheading:16542695-Virus Replication
|
pubmed:year |
2006
|
pubmed:articleTitle |
Interleukin-7 induces HIV replication in primary naive T cells through a nuclear factor of activated T cell (NFAT)-dependent pathway.
|
pubmed:affiliation |
Department of Immunology/Microbiology, Rush University Medical Center, 1735 West Harrison Street, 614 Cohn, Chicago, IL 60612, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|